Bonnetain F - Search Results

1

The heterogeneity of changes in incidence and survival among lymphoid malignancies in a 30-year French population-based registry.

Dandoit M, Mounier M, Guy J, Petrella T, Girard S, Casasnovas RO, Martin L, Bonnetain F, Maynadié M. Dandoit M, et al. Among authors: bonnetain f. Leuk Lymphoma. 2015 Apr;56(4):1050-7. doi: 10.3109/10428194.2014.956315. Epub 2014 Nov 20. Leuk Lymphoma. 2015. PMID: 25166007

2

Population-based study of ovarian cancer in Côte d'Or: prognostic factors and trends in relative survival rates over the last 20 years.

Hamidou Z, Causeret S, Dabakuyo TS, Gentil J, Arnould L, Roignot P, Altwegg T, Poillot ML, Bonnetain F, Arveux P. Hamidou Z, et al. Among authors: bonnetain f. BMC Cancer. 2010 Nov 10;10:622. doi: 10.1186/1471-2407-10-622. BMC Cancer. 2010. PMID: 21067600 Free PMC article.

3

Estimating the cost related to surveillance of colorectal cancer in a French population.

Lejeune C, Binquet C, Bonnetain F, Mahboubi A, Abrahamowicz M, Moreau T, Raikou M, Bedenne L, Quantin C, Bonithon-Kopp C. Lejeune C, et al. Among authors: bonnetain f. Eur J Health Econ. 2009 Oct;10(4):409-19. doi: 10.1007/s10198-009-0144-7. Epub 2009 Mar 4. Eur J Health Econ. 2009. PMID: 19259712 Free PMC article.

4

Adjuvant treatments do not alter the quality of life in elderly patients with colorectal cancer: a population-based study.

Bouvier AM, Jooste V, Bonnetain F, Cottet V, Bizollon MH, Bernard MP, Faivre J. Bouvier AM, et al. Among authors: bonnetain f. Cancer. 2008 Aug 15;113(4):879-86. doi: 10.1002/cncr.23629. Cancer. 2008. PMID: 18521903 Free article.

5

Surrogate endpoints for overall survival in digestive oncology trials: which candidates? A questionnaires survey among clinicians and methodologists.

Methy N, Bedenne L, Bonnetain F. Methy N, et al. Among authors: bonnetain f. BMC Cancer. 2010 Jun 10;10:277. doi: 10.1186/1471-2407-10-277. BMC Cancer. 2010. PMID: 20537166 Free PMC article.

6

Pathological response and survival after neoadjuvant therapy for breast cancer: a 30-year study.

Guiu S, Arnould L, Bonnetain F, Dalban C, Favier L, Desmoulins I, Créhange G, Coutant C, Fumoleau P, Coudert B. Guiu S, et al. Among authors: bonnetain f. Breast. 2013 Jun;22(3):301-8. doi: 10.1016/j.breast.2012.07.012. Epub 2012 Aug 3. Breast. 2013. PMID: 22863283 Free article.

7

Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer.

Mariette C, Markar SR, Dabakuyo-Yonli TS, Meunier B, Pezet D, Collet D, D'Journo XB, Brigand C, Perniceni T, Carrère N, Mabrut JY, Msika S, Peschaud F, Prudhomme M, Bonnetain F, Piessen G; Fédération de Recherche en Chirurgie (FRENCH) and French Eso-Gastric Tumors (FREGAT) Working Group. Mariette C, et al. Among authors: bonnetain f. N Engl J Med. 2019 Jan 10;380(2):152-162. doi: 10.1056/NEJMoa1805101. N Engl J Med. 2019. PMID: 30625052 Clinical Trial.

8

Statistical challenges of quality of life and cancer: new avenues for future research.

Boyer L, Baumstarck K, Michel P, Boucekine M, Anota A, Bonnetain F, Coste J, Falissard B, Guilleux A, Hardouin JB, Loundou A, Mercier M, Mesbah M, Rouquette A, Sebille V, Verdam MG, Ghattas B, Guillemin F, Auquier P. Boyer L, et al. Among authors: bonnetain f. Expert Rev Pharmacoecon Outcomes Res. 2014 Feb;14(1):19-22. doi: 10.1586/14737167.2014.873704. Epub 2013 Dec 30. Expert Rev Pharmacoecon Outcomes Res. 2014. PMID: 24378121

9

Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancer.

Valentini V, van Stiphout RG, Lammering G, Gambacorta MA, Barba MC, Bebenek M, Bonnetain F, Bosset JF, Bujko K, Cionini L, Gerard JP, Rödel C, Sainato A, Sauer R, Minsky BD, Collette L, Lambin P. Valentini V, et al. Among authors: bonnetain f. Radiother Oncol. 2015 Mar;114(3):302-9. doi: 10.1016/j.radonc.2015.02.001. Epub 2015 Feb 21. Radiother Oncol. 2015. PMID: 25716096

10

Impact of response shift on longitudinal quality-of-life assessment in cancer clinical trials.

Hamidou Z, Dabakuyo TS, Bonnetain F. Hamidou Z, et al. Among authors: bonnetain f. Expert Rev Pharmacoecon Outcomes Res. 2011 Oct;11(5):549-59. doi: 10.1586/erp.11.57. Expert Rev Pharmacoecon Outcomes Res. 2011. PMID: 21958100 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters